{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:12:56Z","timestamp":1793052776948,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001720","name":"Nutricia Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001720","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ymgme.2020.01.006","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T02:18:24Z","timestamp":1579141104000},"page":"193-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":157,"title":["Branched-chain \u03b1-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes"],"prefix":"10.1016","volume":"129","author":[{"given":"Kevin A.","family":"Strauss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent J.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Soltys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millie E.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Bowser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik G.","family":"Puffenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlla W.","family":"Brigatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie B.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna L.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Hendrickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keturah","family":"Beiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora M.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Haas-Givler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Chopko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie R.","family":"Muelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana A.","family":"Shellmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Radcliff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlin","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KaLynn","family":"Loeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D.","family":"Heaps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George V.","family":"Mazariegos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Holmes","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2020.01.006_bb0005","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1542\/peds.14.5.462","article-title":"A new syndrome: progressive familial infantile cerebral dysfunction associated with an unusual urinary substance","volume":"14","author":"Menkes","year":"1954","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2020.01.006_bb0010","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/gim.2013.177","article-title":"Developing a public health-tracking system for follow-up of newborn screening metabolic conditions: a four-state pilot project structure and initial findings","volume":"16","author":"Hinton","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ymgme.2014.07.009","article-title":"Inborn errors of metabolism identified via newborn screening: ten-year incidence data and costs of nutritional interventions for research agenda planning","volume":"113","author":"Therrell","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0020","doi-asserted-by":"crossref","first-page":"S295","DOI":"10.1007\/s10545-010-9129-z","article-title":"Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan","volume":"33","author":"Niu","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0025","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1086\/323677","article-title":"Maple syrup urine disease: identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population","volume":"69","author":"Edelmann","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0030","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1172\/JCI67217","article-title":"Biochemical correlates of neuropsychiatric illness in maple syrup urine disease","volume":"123","author":"Muelly","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0035","series-title":"Maple Syrup Urine Disease, GeneReviews","author":"Strauss","year":"2009"},{"key":"10.1016\/j.ymgme.2020.01.006_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2011.06.033","article-title":"Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative United Network for Organ Sharing experience","volume":"160","author":"Mazariegos","year":"2012","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0045","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0050","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ajmg.a.38413","article-title":"Challenges of developing and conducting clinical trials in rare disorders","volume":"176","author":"Kempf","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2020.01.006_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-017-2287-7","article-title":"A systematic literature review of evidence-based clinical practice for rare diseases: what are the perceived and real barriers for improving the evidence and how can they be overcome?","volume":"18","author":"Rath","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.ymgme.2020.01.006_bb0060","series-title":"What is Wrong With Our Baby?","year":"1995"},{"key":"10.1016\/j.ymgme.2020.01.006_bb0065","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ymgme.2009.12.007","article-title":"Classical maple syrup urine disease and brain development: principles of management and formula design","volume":"99","author":"Strauss","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0070","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1023\/A:1005540016376","article-title":"Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease","volume":"22","author":"Schadewaldt","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0075","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1203\/00006450-199805000-00006","article-title":"Assessment of whole body L-leucine oxidation by noninvasive L-[1-13C]leucine breath tests: a reappraisal in patients with maple syrup urine disease, obligate heterozygotes, and healthy subjects","volume":"43","author":"Schadewaldt","year":"1998","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0080","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ymgme.2007.02.012","article-title":"Prevention of brain disease from severe 5,10-methylenetetrahydrofolate reductase deficiency","volume":"91","author":"Strauss","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1172\/JCI105155","article-title":"Body composition in severe infantile malnutrition","volume":"44","author":"Garrow","year":"1965","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0090","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s00726-018-2640-5","article-title":"Protein content and amino acid composition of commercially available plant-based protein isolates","volume":"50","author":"Gorissen","year":"2018","journal-title":"Amino Acids"},{"key":"10.1016\/j.ymgme.2020.01.006_bb0095","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0003-9861(52)90132-X","article-title":"Amino acid composition of some human tissues","volume":"40","author":"Bocobo","year":"1952","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0261-5614(97)80015-5","article-title":"Simultaneous measurements of free amino acid patterns of plasma, muscle and erythrocytes in healthy human subjects","volume":"16","author":"Filho","year":"1997","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0105","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/clinchem\/45.10.1734","article-title":"Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease","volume":"45","author":"Schadewaldt","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0110","series-title":"Introduction to the Blood-Brain Barrier","first-page":"188","article-title":"Blood-brain barrier amino acid transport","author":"Smith","year":"1998"},{"key":"10.1016\/j.ymgme.2020.01.006_bb0115","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1749-6632.1986.tb27150.x","article-title":"Kinetics of amino acid transport at the blood-brain barrier studied using an in situ brain perfusion technique","volume":"481","author":"Smith","year":"1986","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"Pt 3","key":"10.1016\/j.ymgme.2020.01.006_bb0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2788.1999.00187.x","article-title":"Reliability, criterion-related validity and qualitative comments of the fourth edition of the Stanford-Binet intelligence scale with a young adult population with intellectual disability","volume":"43","author":"Dacey","year":"1999","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0125","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/humu.22242","article-title":"A novel regulatory defect in the branched-chain alpha-keto acid dehydrogenase complex due to a mutation in the PPM1K gene causes a mild variant phenotype of maple syrup urine disease","volume":"34","author":"Oyarzabal","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0130","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1007\/s00134-001-1124-2","article-title":"Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease","volume":"27","author":"Jouvet","year":"2001","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00467-001-0801-2","article-title":"Utility of hemodialysis in maple syrup urine disease","volume":"17","author":"Puliyanda","year":"2002","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0140","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/ajcn\/46.5.709","article-title":"1987 McCollum award lecture. Kinetics of human amino acid metabolism: nutritional implications and some lessons","volume":"46","author":"Young","year":"1987","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0145","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/lt.20744","article-title":"Domino liver transplantation in maple syrup urine disease","volume":"12","author":"Khanna","year":"2006","journal-title":"Liver Transplant."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0150","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1542\/peds.109.6.999","article-title":"Diagnosis and treatment of maple syrup disease: a study of 36 patients","volume":"109","author":"Morton","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2020.01.006_bb0155","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2105\/AJPH.2011.300569","article-title":"One community\u2019s effort to control genetic disease","volume":"102","author":"Strauss","year":"2012","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ymgme.2020.01.006_bb0160","first-page":"54","article-title":"Treatment adherence during childhood in individuals with phenylketonuria: early signs of treatment discontinuation","volume":"11","author":"Garcia","year":"2017","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0165","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ejcn.2010.258","article-title":"Blood phenylalanine control in phenylketonuria: a survey of 10 European centres","volume":"65","author":"Ahring","year":"2011","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0170","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10545-017-0083-x","article-title":"Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease","volume":"40","author":"Abi-Warde","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0887-8994(92)90038-Z","article-title":"Abnormal dendritic development in maple syrup urine disease","volume":"8","author":"Kamei","year":"1992","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0180","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0197-0186(01)00077-8","article-title":"Large neutral amino acids auto exchange when infused by microdialysis into the rat brain: implication for maple syrup urine disease and phenylketonuria","volume":"40","author":"Zielke","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0185","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1471-4159.1992.tb09409.x","article-title":"Glutamate and gamma-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves","volume":"59","author":"Dodd","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0190","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/brain\/awp024","article-title":"Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease","volume":"132","author":"Zinnanti","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2020.01.006_bb0195","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1046\/j.1471-4159.1994.63041508.x","article-title":"Inhibition of astrocyte glutamine production by alpha-ketoisocaproic acid","volume":"63","author":"Yudkoff","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0200","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1542\/peds.94.6.785","article-title":"Through my window--remarks at the 125th year celebration of Children's Hospital of Boston","volume":"94","author":"Morton","year":"1994","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2020.01.006_bb0205","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jped.2014.08.010","article-title":"Maple syrup urine disease in Brazil: a panorama of the last two decades","volume":"91","author":"Herber","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0210","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.clinbiochem.2013.08.009","article-title":"Diagnostic challenges of aminoacidopathies and organic acidemias in a developing country: a twelve-year experience","volume":"46","author":"Karam","year":"2013","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12687-016-0281-5","article-title":"Challenges in the management of patients with maple syrup urine disease diagnosed by newborn screening in a developing country","volume":"8","author":"De Castro-Hamoy","year":"2017","journal-title":"J. Commun. Genet."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0220","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10545-010-9216-1","article-title":"Large neutral amino acids in the treatment of PKU: from theory to practice","volume":"33","author":"van Spronsen","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0225","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s10545-007-0475-4","article-title":"Social outcome in adults with maple syrup urine disease (MSUD)","volume":"30","author":"Simon","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0230","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00004703-198512000-00007","article-title":"Psychological adaptation of siblings of chronically ill children: research and practice implications","volume":"6","author":"Drotar","year":"1985","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0235","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/cch.12421","article-title":"Siblings of children with life-limiting conditions: psychological adjustment and sibling relationships","volume":"43","author":"Fullerton","year":"2017","journal-title":"Child Care Health Dev."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0240","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/09638288.2016.1251500","article-title":"Complete mental health in adult siblings of those with a chronic illness or disability","volume":"40","author":"Hallion","year":"2018","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0245","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1399-3046.2010.01411.x","article-title":"Cognitive and adaptive functioning after liver transplantation for maple syrup urine disease: a case series","volume":"15","author":"Shellmer","year":"2011","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0250","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/ajcn\/68.1.72","article-title":"A molecular model of human branched-chain amino acid metabolism","volume":"68","author":"Suryawan","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0255","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2020.01.006_bb0260","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219312910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219312910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:24:21Z","timestamp":1761089061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719219312910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1096719219312910"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.01.006","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Branched-chain \u03b1-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}